These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9728575)

  • 21. A rapid immunoblotting procedure for detecting serum antibodies to the lipopolysaccharide of Escherichia coli O157.
    Chart H; Montgomery S; Rowe B
    Lett Appl Microbiol; 1994 Feb; 18(2):100-1. PubMed ID: 7764593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and serologic properties of O-specific polysaccharide from Citrobacter freundii possessing cross-reactivity with Escherichia coli O157:H7.
    Nishiuchi Y; Doe M; Hotta H; Kobayashi K
    FEMS Immunol Med Microbiol; 2000 Jun; 28(2):163-71. PubMed ID: 10799808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues.
    Nnalue NA
    Infect Immun; 1999 Feb; 67(2):998-1003. PubMed ID: 9916124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal antibody responses of colonized cattle to Escherichia coli O157-secreted proteins, flagellin, outer membrane proteins and lipopolysaccharide.
    Nart P; Holden N; McAteer SP; Wang D; Flockhart AF; Naylor SW; Low JC; Gally DL; Huntley JF
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):59-68. PubMed ID: 17995963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence and risk factors associated with Escherichia coli O157 in a farming population.
    Quilliam RS; Chalmers RM; Williams AP; Chart H; Willshaw GA; Kench SM; Edwards-Jones G; Evans J; Thomas DR; Salmon RL; Jones DL
    Zoonoses Public Health; 2012 Mar; 59(2):83-8. PubMed ID: 21884032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection by 5'-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world's most frequent clinical cases.
    Perelle S; Dilasser F; Grout J; Fach P
    Mol Cell Probes; 2004 Jun; 18(3):185-92. PubMed ID: 15135453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrogation of single nucleotide polymorphisms in gnd provides a novel method for molecular serogrouping of clinically important Shiga toxin producing Escherichia coli (STEC) targeted by regulation in the United States, including the "big six" non-O157 STEC and STEC O157.
    Elder JR; Bugarel M; den Bakker HC; Loneragan GH; Nightingale KK
    J Microbiol Methods; 2016 Oct; 129():85-93. PubMed ID: 27432340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus.
    Jenkins C; Chart H; Smith HR; Hartland EL; Batchelor M; Delahay RM; Dougan G; Frankel G
    J Med Microbiol; 2000 Jan; 49(1):97-101. PubMed ID: 10628831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic heterogeneity of Shiga toxin-producing Escherichia coli strains isolated in Sao Paulo, Brazil, from 1976 through 2003, as revealed by pulsed-field gel electrophoresis.
    Vaz TM; Irino K; Nishimura LS; Cergole-Novella MC; Guth BE
    J Clin Microbiol; 2006 Mar; 44(3):798-804. PubMed ID: 16517857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7.
    Cheasty T; Robertson R; Chart H; Mannion P; Syed Q; Garvey R; Rowe B
    J Clin Pathol; 1998 Jul; 51(7):498-501. PubMed ID: 9797724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.
    Ahmed A; Li J; Shiloach Y; Robbins JB; Szu SC
    J Infect Dis; 2006 Feb; 193(4):515-21. PubMed ID: 16425130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes.
    Asper DJ; Sekirov I; Finlay BB; Rogan D; Potter AA
    Vaccine; 2007 Nov; 25(49):8262-9. PubMed ID: 17980466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a LPS-based glycoconjugate vaccine against bovine Escherichia coli mastitis: Formation of LPS Abs in cows after immunization with E. coli core oligosaccharides conjugated to hemocyanine.
    Brade L; Hensen S; Brade H
    Innate Immun; 2013; 19(4):368-77. PubMed ID: 23112009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shiga Toxin Subtypes of Non-O157
    Shridhar PB; Siepker C; Noll LW; Shi X; Nagaraja TG; Bai J
    Front Cell Infect Microbiol; 2017; 7():121. PubMed ID: 28443248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New system for multilocus variable-number tandem-repeat analysis of the enterohemorrhagic Escherichia coli strains belonging to three major serogroups: O157, O26, and O111.
    Izumiya H; Pei Y; Terajima J; Ohnishi M; Hayashi T; Iyoda S; Watanabe H
    Microbiol Immunol; 2010 Oct; 54(10):569-77. PubMed ID: 21118294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of O-antigen chain length by the wzz gene in Escherichia coli O157 influences its sensitivities to serum complement.
    Osawa K; Shigemura K; Iguchi A; Shirai H; Imayama T; Seto K; Raharjo D; Fujisawa M; Osawa R; Shirakawa T
    Microbiol Immunol; 2013 Sep; 57(9):616-23. PubMed ID: 23865758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome.
    Ludwig K; Bitzan M; Zimmermann S; Kloth M; Ruder H; Müller-Wiefel DE
    J Infect Dis; 1996 Nov; 174(5):1028-39. PubMed ID: 8896505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further characterisation of a monoclonal antibody reactive with Escherichia coli O157:H7.
    Clark CG; Johnson S; Johnson RP
    J Med Microbiol; 1995 Oct; 43(4):262-9. PubMed ID: 7562987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.